Metrion leases facility, adds high-throughput capacity to support ion channel services
Metrion Biosciences has leased a new facility and added high-throughput screening (HTS) capacity to support its ion channel drug discovery projects.
Headlines
Global Industry News
-
The Native Antigen Company expands portfolio to support research into vaccines targeting Sudan Ebolavirus
from BioPharma-Reporter.com
-
FDA expected to make decision on Pfizer RSV vaccine in May
from BioPharma-Reporter.com
-
Oral biologics: Rani reports positive clinical data for osteoporosis targeting capsule
from BioPharma-Reporter.com
-
Intravacc launches phase 1 trial for intranasal COVID-19 booster vaccine
from BioPharma-Reporter.com
Hot Topics
-
‘Data is the key’: Strategic partnership leverages AI for cancer clinical trial placement
Clinical evolution
-
OneStudyTeam, Antidote partner to support clinical trial recruitment and enrollment
Patient centricity
-
Survey reveals decentralized clinical trial elements that drive participation in studies
Patient centricity
-
Castor bolsters trial solutions platforms to reach more patients and gain RWE
Clinical evolution
Spotlight
Follow us
Products
View moreWebinars
Featured Suppliers
All suppliers-
Altasciences |
Ancillare |
Baxter BioPharma Solutions |
CellCarta |
Curia |
eClinical Solutions |
Firma Clinical Research |
Formedix |
JRS PHARMA |
Lonza Small Molecules |
Piramal Pharma Solutions |
PPD - Decentralized Clinical Trials |
Signant Health |
Softigel by Procaps |
Symbiosis Pharmaceutical Services |
THREAD |
TripleTree |
Veeva